BLK vs CRBP · P/E 27, rev $24.22B vs $102.3M cap
BlackRock Inc (BLK) versus Corbus Pharmaceuticals Holding (CRBP) — a side-by-side from cached financials, not a winner call.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.
Corbus Pharmaceuticals Holding (CRBP) is a biotechnology company listed on US.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
CRBP does not have a complete income-statement cache yet.
BLK currently screens at market cap $172.19B and trailing P/E 26.6. CRBP currently screens at market cap $102.3M.
Not investment advice. Open the BLK and CRBP stock pages for the full models.
Not investment advice.